Science
Novo Nordisk Shares Rise After Wegovy Obesity Pill Launch
By CNBC
Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company's new GLP-1 pill for obesity.
In a Friday note, TD Cowen analysts called it a "solid start" for the first-e ...Read more